Parmax Pharma posts Q1 FY 23 loss at Rs. 1.31 Cr
News

Parmax Pharma posts Q1 FY 23 loss at Rs. 1.31 Cr

The company has reported total income of Rs. 1.56 crores during the period ended June 30, 2022

  • By IPP Bureau | August 14, 2022

Parmax Pharma Ltd has posted net loss of Rs. 1.31 crores for the period ended June 30, 2022 as against net loss of Rs. 0.04 crores for the period ended March 31, 2022. The company posted net loss of Rs. 0.43 crores for the period ended June 30, 2021.

The company has reported total income of Rs. 1.56 crores during the period ended June 30, 2022 as compared to Rs. 7.10 crores during the period ended March 31, 2022. It reported total income of Rs.1.75 crores during the period ended June 30, 2021.

Upcoming E-conference

Other Related stories

Startup

Digitization